BioCryst Pharmaceuticals BCRX Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
- BioCryst Pharmaceuticals (BCRX) reported effective income tax rate reconciliation, other adjustments, amount of $1.23M in Q4 2025.
- How has BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount changed year-over-year?
- BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount increased by 4704.7% year-over-year, from -$26.75K to $1.23M.
- What is the long-term trend for BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount has grown at a 41.9% compound annual growth rate (CAGR), from $1.22M to $4.93M.